Literature DB >> 7118722

Studies of tylosin derivatives effective against macrolide-resistant strains: synthesis and structure-activity relationships.

M Tsuchiya, M Hamada, T Takeuchi, H Umezawa, K Yamamoto, H Tanaka, K Kiyoshima, S Mori, R Okamoto.   

Abstract

The 4"-O-substituted tylosin derivatives were prepared by selective esterification of the 4"-OH, and relationships between the substituent groups and antimicrobial activity against macrolide-resistant strains were examined. Introduction of branched-chain aliphatic acyl groups such as 2-methoxyisovaleryl or 4-methylvaleryl group afforded derivatives with good antibacterial activity; MIC values were 12.5 microgram/ml against Staphylococcus aureus MS-8710. MIC values of tylosin, erythromycin and josamycin against this strain were 800 microgram/ml or more. Further improved activity was obtained by introduction of aromatic groups such as phenylthioacetyl, phenylsulfonylacetyl, 4-nitrophenylacetyl, 4-nitrophenylsulfonyl and phenylethanesulfonyl groups; MIC values were 6.25 microgram/ml. These derivatives had also an improved antimycoplasmal activity; MIC values were 0.08 microgram/ml against macrolide-resistant strains of Mycoplasma gallisepticum. MIC values of tylosin against these strains were from 2.5 to 10 microgram/ml. Introduction of the groups described above into the 4"-OH was confirmed to increase the uptake by a resistant strain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118722     DOI: 10.7164/antibiotics.35.661

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  In vitro activity of YM133, a new semisynthesized macrolide.

Authors:  T Terasawa; M Watanabe; T Okubo; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.

Authors:  Thomas W von Geldern; Howard E Morton; Rick F Clark; Brian S Brown; Kelly L Johnston; Louise Ford; Sabine Specht; Robert A Carr; Deanne F Stolarik; Junli Ma; Matthew J Rieser; Dominique Struever; Stefan J Frohberger; Marianne Koschel; Alexandra Ehrens; Joseph D Turner; Marc P Hübner; Achim Hoerauf; Mark J Taylor; Stephen A Ward; Kennan Marsh; Dale J Kempf
Journal:  PLoS Negl Trop Dis       Date:  2019-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.